Tuberculosis (TB) remains one of the world’s most persistent infectious diseases, affecting millions each year — especially in communities where access to early testing is limited. Yet, TB is preventable, treatable, and curable. The key is early detection. Delays in diagnosis increase the risk of severe illness, long treatment cycles, and continued transmission within households and communities. When individuals can test early, they can seek treatment sooner — protecting themselves and others.
We are committed to making early TB testing accessible, simple, and affordable for every community. Our rapid TB antigen testing solutions support:
Early screening in community and primary care settings
Outreach and door-to-door health initiatives
Decentralized and mobile testing environments
Linkage to confirmatory diagnostics and treatment
By complementing laboratory-based testing, we help health systems detect TB earlier, reduce transmission, and protect more lives.